What are the alternative treatment options for relapsed or elderly AML patients?
Exciting novel AML treatment: venetoclax plus cobimetinib or idasanutlin in elderly patients
AL amyloidosis and a critical, early diagnosis
Exploring combinatorial approaches in acute myeloid leukemia (AML) treatment
MRD negativity and its role as a predictor for CLL patient responses